Loading clinical trials...
Loading clinical trials...
Schizophrenia spectrum disorders are associated with impairment in the microstructure of white matter, the key brain tissue responsible for fast communication between different brain regions necessary...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of Maryland, Baltimore
NCT07010614 · Schizophrenia Disorders, Mental Disorder, and more
NCT06939088 · Alcohol Use Disorder, Alcohol Abuse/Dependence, and more
NCT06674694 · Schizophrenia Disorders
NCT07091344 · Schizophrenia Disorders, Treatment Resistant Hallucinations
NCT06936397 · Schizophrenia Disorders, Cognitive Dysfunction, and more
Maryland Psychiatric Research Center
Catonsville, Maryland
University of Maryland Baltimore - Maryland Psychiatric Research Center
Catonsville, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions